BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance

U.S. Markets open in 9 hrs 19 mins

Bristol-Myers Squibb Company (BMY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
55.95-0.25 (-0.44%)
At close: 4:00PM EDT
People also watch
MRKLLYABTPFEJNJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close56.20
Open56.17
Bid0.00 x
Ask0.00 x
Day's Range55.92 - 56.55
52 Week Range46.01 - 77.12
Volume6,136,155
Avg. Volume13,252,124
Market Cap93.59B
Beta0.96
PE Ratio (TTM)21.11
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.56 (2.78%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investopedia7 hours ago

    Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage

    Shares of Athersys, Inc. ATHX surged significantly in the post market trading on Mar 28 after research firm William Blair initiated a coverage on the stock with an outperform rating. Share Price Movement ...

  • Reuters7 hours ago

    U.S. FDA nominee moves to untangle potential conflicts of interest

    Dr. Scott Gottlieb, President Donald Trump's nominee to lead the U.S. Food and Drug Administration, has outlined measures he would take to untangle his ties to the pharmaceutical industry if confirmed by the Senate. In an ethics disclosure form filed with the Department of Health and Human Services on Tuesday, Gottlieb said he would resign from multiple corporate boards including GlaxoSmithKline Plc and consulting positions. Gottlieb's financial ties to the healthcare industry are extensive.

  • Investopedia10 hours ago

    Nominee’s industry ties risk side effects for FDA

    (The author is a Reuters Breakingviews columnist. The opinions expressed are his own.)